Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 17/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278097 | 0.83 | — | — | |
| SCHEMBL278231 | 0.78 | CRBN (0.41) | CRBNDDB1TSHRNPSR1IDO1 | |
| SCHEMBL3825820 | 0.76 | CRBN (0.40) | CRBNDDB1TSHRNPSR1 | |
| SCHEMBL3958832 | 0.76 | CRBN (0.40) | CRBNDDB1TSHRNPSR1 | |
| SCHEMBL785575 | 0.74 | CRBN (0.55) | CRBNDDB1TSHRNPSR1IDO1 | |
| SCHEMBL17077711 | 0.73 | CRBN (0.38) | CRBNDDB1TSHRNPSR1IDO1 | |
| Hydrochloric Acid SCHEMBL5258578 | 0.73 | CRBN (0.53) | CRBNDDB1TSHRNPSR1 | |
| SCHEMBL15898067 | 0.71 | CRBN (0.39) | CRBNDDB1TSHRNPSR1 | |
| SCHEMBL21049515 | 0.71 | CRBN (0.37) | CRBNDDB1TSHRNPSR1IDO1 | |
| SCHEMBL769784 | 0.70 | CRBN (0.32) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448926-A1 | FLAVIN DERIVATIVES | Biorelix, Inc. (US) | 2012-05-09 | — | — | EP | claimed |
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLOUNT KENNETH F (US) | 2012-11-22 | — | — | US | disclosed |
| EP-2448926-A1 | FLAVIN DERIVATIVES | Biorelix, Inc. (US) | 2012-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLVRB, FLAD1, FDPS | CRBN 4822/4885DDB1 623/4885TSHR 2380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.